[1] Espinal M A，Laszlo A,Simonsen L,et al. Global trends in resistance to antituberculosis drugs [J]. N Engl J Med,344(17): 1294-1303.
[2] WHO/IUATLD. Anti-tuberculosis drug resistance in the world [M]. The WHO/IUATLD Global Projects on Anti-tuberculosis Drug Resistance Surveillance 1994～1997. WHO/TB/1997.299.
[3] 全国结核病流行病学抽样调査技术指导组.2000年全国结核病流行病学抽样调查报告[J].中国防痨杂志，2002,24(2):65～107.
[4] Zhang L X, Tu D H,Enarson D A. The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing [J]. Int J Tuberc Lung Dis,2000,4(l0):904～910.
[5] CDC.TB Elimination：Now is the time. Center for Disease Control and Prevenlion.2002.
[6] WHO. The DOTS-PIus ＆ Green Light Committee,Improving access to second-line anti-TB drugs [M]. World Health Organization, WHO/CDS/TB/2000.283.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
